Faculty Spotlight: David R. Hinton
David Hinton’s research is focused on developing novel therapies for age-related macular degeneration (AMD) – the leading cause of irreversible blindness in the elderly. He is approaching this goal in two main …
Announcements
CIRM-funded clinical trial aimed at blocking HIV/AIDS in people gets the go ahead
An innovative therapy using a patient’s own stem cells, modified to resist infection with the AIDS virus, has been given approval by the Food and Drug Administration (FDA) to begin a clinical …
“Million-dollar ideas” seminar
At a special seminar on February 24, USC Stem Cell Principal Investigators discussed their “million-dollar ideas” for creating new tools and technologies to usher in the era of regenerative medicine. They shared …
USC summit marks rebirth of biotech era in Los Angeles
Los Angeles city and county policymakers and educational institutions laid the groundwork for the region’s biotechnology strategy at a summit on the USC Health Sciences Campus. The Los Angeles Biotech Summit drew …
Janet Moradian-Oldak Receives 2015 IADR Innovation in Oral Care Award
USC Stem Cell principal investigator Janet Moradian-Oldak has earned a 2015 IADR Innovation in Oral Care Award. The prestigious award, which can be worth up to $75,000 and lasts one year, was …
Three USC researchers win $4.3 million in awards from California’s stem cell agency
Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding …
New option benefits patients needing bone marrow transplants
Keck Medical Center of USC is offering a new option for patients who need bone marrow (also called stem cell) transplants, but have not found a match. Haploidentical transplants allow patients who …
Protein-based therapy shows promise against resistant leukemia
Resistance of leukemia cells to contemporary chemotherapy is one of the most formidable obstacles to treating acute lymphoblastic leukemia (ALL), the most common form of childhood cancer. Now researchers at Children’s Hospital …
The Hearst Foundations establish stem cell fellowships at USC
It takes more than materials and methods to be a successful young scientist — it also takes means. With this in mind, the Hearst Foundations have given a gift of $250,000 to …
USC Stem Cell Symposium creates scientific synergy
Provost Michael Quick convened the inaugural USC Stem Cell Symposium with a straightforward truth about the future of regenerative medicine: “it will take a dedicated community of scholars across the disciplines to …